Aspen Aerogels, Inc. (NYSE:ASPN) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eleven analysts that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $18.44.

A number of equities research analysts recently weighed in on the stock. B. Riley reduced their price target on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a research report on Wednesday, February 19th. Seaport Res Ptn cut Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. TD Cowen raised Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th. Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. Finally, Roth Mkm reduced their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a research note on Friday, February 14th.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young purchased 20,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was purchased at an average cost of $5.35 per share, with a total value of $107,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 550,856 shares of the company's stock, valued at approximately $2,947,079.60. This trade represents a 3.77% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 3.40% of the company's stock.

Hedge Funds Weigh In On Aspen Aerogels

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Abbot Financial Management Inc. grew its holdings in Aspen Aerogels by 3.9% during the fourth quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company's stock worth $359,000 after acquiring an additional 1,146 shares during the period. Invesco Ltd. boosted its position in shares of Aspen Aerogels by 3.5% during the 4th quarter. Invesco Ltd. now owns 50,871 shares of the construction company's stock worth $604,000 after purchasing an additional 1,724 shares in the last quarter. Greenwood Capital Associates LLC boosted its position in shares of Aspen Aerogels by 5.0% during the 4th quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company's stock worth $439,000 after purchasing an additional 1,749 shares in the last quarter. Alps Advisors Inc. grew its stake in shares of Aspen Aerogels by 1.7% during the 1st quarter. Alps Advisors Inc. now owns 126,326 shares of the construction company's stock worth $807,000 after purchasing an additional 2,093 shares during the period. Finally, MetLife Investment Management LLC increased its holdings in shares of Aspen Aerogels by 6.3% in the 4th quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company's stock valued at $425,000 after purchasing an additional 2,118 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Stock Down 7.1%

NYSE:ASPN traded down $0.46 during trading hours on Friday, hitting $5.97. The company's stock had a trading volume of 2,347,738 shares, compared to its average volume of 2,004,990. Aspen Aerogels has a 52-week low of $4.16 and a 52-week high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $489.76 million, a P/E ratio of 37.28 and a beta of 2.72. The stock has a fifty day moving average of $5.74 and a 200-day moving average of $9.43.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The construction company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The business had revenue of $78.72 million for the quarter, compared to the consensus estimate of $82.75 million. During the same quarter in the prior year, the business posted ($0.02) EPS. The business's revenue for the quarter was down 16.7% on a year-over-year basis. On average, equities analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.